Immunisation and vaccines
Vaccination protects people against serious and life-threatening infectious diseases, such as influenza (flu), diphtheria, tetanus, pertussis (whooping cough), measles, mumps, rubella (German measles), meningococcal disease, invasive pneumococcal disease and polio.
Each year, vaccination stops 2.7 million people worldwide from getting measles, one million from getting pertussis and two million babies from getting tetanus.
In the past, many people died of diseases that can now be prevented through vaccination. People also suffered more commonly from disease-related complications, such as blindness due to measles and babies born with deafness, cataracts or learning disabilities due to their mothers getting rubella in pregnancy. Polio - as many people born before the 60's will remember - used to be a major cause of death, paralysis and lifelong disabilities in Europe and other regions.
Vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite availability of vaccination services.
The proportion of the EU population who receive the recommended vaccine against diseases.
EU vaccination schedules
The Vaccine Schedule is an ECDC tool and interactive platform of vaccination schedules for individual European countries and specific age groups.
Immunisation Information Systems
Strong information systems to digitally record information about vaccination, Immunisation Information Systems (IIS), are an integral part of well-functioning vaccine programmes.
European Immunisation Week
European Immunisation Week (EIW) is celebrated across the European Region every April to raise awareness of the importance of immunization for people’s health and well-being.
Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities, version 2.0
ECDC awards 77 M€ to strengthen EU/EEA Member States’ capacities to detect and identify SARS-CoV-2 variants
Combined indicator: 14-day notification rate, testing rate and test positivity, updated 16 September 2021 (colour-blind friendly), weeks 35-36
Combined indicator: 14-day notification rate, testing rate and test positivity, updated 16 September 2021, weeks 35-36
To what extent does evidence support decision making during infectious disease outbreaks? A scoping literature review
Natural disasters and infectious disease in Europe: A literature review to identify cascading risk pathways
Human papillomavirus vaccination coverage, policies, and practical implementation across Europe